Skip to main content
. Author manuscript; available in PMC: 2013 Oct 1.
Published in final edited form as: Bone Marrow Transplant. 2012 Feb 13;47(10):1312–1317. doi: 10.1038/bmt.2012.1

Figure 1.

Figure 1

Probabilities of overall survival (OS) and progression free survival (PFS) for patients undergoing myeloablative or nonmyeloablative allogeneic hematopoietic cell transplants.

Top line: overall survival of 134 patients undergoing nonmyeloabaltive allografting, Second line: progression-free survival of 134 patients undergoing nonmyeloabaltive allografting, 3rd line: overall survival of 144 patients undergoing myeloablative allografting, 4th line:progression-free survival of 144 patients undergoing myeloablative allografting